Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.

@article{Matera2010PharmacologicalMO,
  title={Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.},
  author={Maria Gabriella Matera and Eugenio Martuscelli and Mario Cazzola},
  journal={Pulmonary pharmacology & therapeutics},
  year={2010},
  volume={23 1},
  pages={1-8}
}
Pharmacological modulation of beta-adrenoceptor function is one of the critical issues in the treatment of patients with concurrent chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF). A volume of published evidence sustains the role of long-acting beta(2)-agonists in the treatment of stable COPD, but beta-agonists seem to be detrimental when used for long term in CHF. beta(2)-agonists may exacerbate heart failure and, in any case, they induce adverse cardiac effects in… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 116 references

Bleecker ER clinical consequences of ADRb2 polymorphisms

  • GA Hawkins, ST Weiss
  • Pharmacogenomics
  • 2008
Highly Influential
5 Excerpts

Similar Papers

Loading similar papers…